by
Thomas Dworetzky, Contributing Reporter | July 10, 2017
For example, in 2015, Konica Minolta developed advanced immunostaining technology, High-Sensitivity Tissue Testing (HSTT). This makes use of fluorescent nanoparticles to detect and quantify the proteins.
Ambry's genetics screening techniques will “further enhance” HSTT, according to Konica Minolta, by letting physicians “analyze both tumor and normal tissue to diagnose hereditary cancer, while also providing guidance regarding drug eligibility and response.”
Ad Statistics
Times Displayed: 45539
Times Visited: 1299 Ampronix, a Top Master Distributor for Sony Medical, provides Sales, Service & Exchanges for Sony Surgical Displays, Printers, & More. Rely on Us for Expert Support Tailored to Your Needs. Email info@ampronix.com or Call 949-273-8000 for Premier Pricing.
“The combination of these bioinformatics capabilities, alongside Konica Minolta’s HSTT technology, will create new opportunities for drug discovery and clinical trials not currently available,” said Kiyotaka Fujii, senior executive officer, president, Global Healthcare, Konica Minolta.
In 2016, Ambry made anonymized data from 10,000 customers publicly available on AmbryShare. Such data collections are vital for researchers to determine underlying genetic causes of disease.
“We’re going to discover a lot of new diagnostic targets and a lot of new drug targets,” Elliott
told the New York Times at the time. “With our volume, we can pull out a significant number of genes just by the sheer number we are looking at.”
The move was “applauded” by Edward Abrahams, president of the Personalized Medicine Coalition, according to the paper.
Part of the reason for making the information available for free came from Dunlop, who said the company had spent $20 million on the effort.
“I’ve got Stage 4 cancer myself,” he told the Times about his own prostate disease, then in remission. “I don’t want to wait an extra day.”
Konica was in the news in February when it showed its new Exa Enterprise Imaging Platform at HIMSS 2017.
Andrew Horning, Konica Minolta Cardiology Product Manager,
told HCB News at the time that it is the only server-side rendering diagnostic zero footprint universal viewer for DICOM and non-DICOM images.
“Exa does not push large files — data is not in motion, no pre-fetching is required,” Horning said. “The server does all the work and it’s instantaneous — similar to how Gmail operates.”
Back to HCB News
